Hologic, Inc. (HOLX) announced the company posted strong results in its second fiscal quarter, with both revenues and non-GAAP EPS exceeding its guidance ranges. The company said its growth was again driven by its Breast Health and Molecular Diagnostics business. Based on its strong performance in the fiscal second quarter, Hologic increased full-year guidance for revenue and non-GAAP EPS.
from RTT - Earnings http://bit.ly/2WjXWVp
via IFTTT
No comments:
Post a Comment